metformin "teva b.v." 500 mg filmovertrukne tabletter
teva b.v. - metforminhydrochlorid - filmovertrukne tabletter - 500 mg
sitagliptin/metformin "krka" 50+1000 mg filmovertrukne tabletter
krka d.d. novo mesto - metforminhydrochlorid, sitagliptin - filmovertrukne tabletter - 50+1000 mg
sitagliptin/metformin "sandoz" 50+1000 mg filmovertrukne tabletter
sandoz a/s - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
sitagliptin/metformin "orion" 50+850 mg filmovertrukne tabletter
orion corporation - metforminhydrochlorid, sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50+850 mg
sitagliptin/metformin "stada" 50+850 mg filmovertrukne tabletter
stada arzneimittel ag - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+850 mg
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin/metformin "grindeks" 50+850 mg filmovertrukne tabletter
as grindeks - metforminhydrochlorid, sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50+850 mg
sitagliptin/metformin "glenmark" 50+1000 mg filmovertrukne tabletter
glenmark arzneimittel gmbh - metforminhydrochlorid, sitagliptinhydrochlorid - filmovertrukne tabletter - 50+1000 mg
sitagliptin/metformin "reddy" 50+850 mg filmovertrukne tabletter
reddy holding gmbh - metforminhydrochlorid, sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50+850 mg
sitagliptin/metformin "zentiva" 50+1000 mg filmovertrukne tabletter
zentiva k.s. - metforminhydrochlorid - filmovertrukne tabletter - 50+1000 mg